Table 3.
Statins at STEMI Discharge | Global (n = 344) | Men (n = 290) | Women (n = 54) | p Value |
---|---|---|---|---|
High-intensity statins | 295 (85.8%) | 246 (84.8%) | 49 (90.8%) | 0.5471 |
Medium-intensity statins | 15 (4.3%) | 13 (4.5%) | 3 (3.7%) | |
Statins + fibrates or ezetimibe | 19 (5.5%) | 18 (6.2%) | 1 (1.9%) | |
Without statins at discharge | 2 (0.6%) | 2 (0.7%) | 0 (0%) | |
Unavailable | 13 (3.8%) | 11 (3.8%) | 2 (3.7%) |